126 related articles for article (PubMed ID: 15620146)
41. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
42. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
[No Abstract] [Full Text] [Related]
43. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
Xu Y; Wu Z; Tao Z; Hua Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
[TBL] [Abstract][Full Text] [Related]
44. The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis.
Mehta D; Daudia A; Birchall JP; Banerjee AR
Acta Otolaryngol; 2007 Feb; 127(2):138-42. PubMed ID: 17364344
[TBL] [Abstract][Full Text] [Related]
45. Management of cholesteatoma: status of the canal wall.
Syms MJ; Luxford WM
Laryngoscope; 2003 Mar; 113(3):443-8. PubMed ID: 12616194
[TBL] [Abstract][Full Text] [Related]
46. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
47. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
Yu Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
[TBL] [Abstract][Full Text] [Related]
48. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
49. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
[TBL] [Abstract][Full Text] [Related]
50. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
Schmidt M; Grünsfelder P; Hoppe F
Eur Arch Otorhinolaryngol; 2001 Nov; 258(9):472-6. PubMed ID: 11769995
[TBL] [Abstract][Full Text] [Related]
51. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
52. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
Zhang E; Gong S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
[TBL] [Abstract][Full Text] [Related]
53. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
54. [Clinical characteristics and surgical management of extensive cholesteatoma of external auditory canal].
Wang H; Yu F; Shan X; Zhang F; Long S; Gao Y; Zhao L; Han D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(10):468-72. PubMed ID: 23937009
[TBL] [Abstract][Full Text] [Related]
55. [Pathophysiology of cholesteatoma].
Gersdorff MC; Debaty ME; Tomasi JP
Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):115-9. PubMed ID: 17007181
[TBL] [Abstract][Full Text] [Related]
56. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
Liu Y; Cui Y; Yu L; Zhang P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
[TBL] [Abstract][Full Text] [Related]
57. Cadmium exposure inhibits MMP2 and MMP9 activities in the prostate and testis.
Lacorte LM; Rinaldi JC; Justulin LA; Delella FK; Moroz A; Felisbino SL
Biochem Biophys Res Commun; 2015 Feb; 457(4):538-41. PubMed ID: 25600809
[TBL] [Abstract][Full Text] [Related]
58. The Role of Rho/Rho-Kinase Pathway in the Pathogenesis of Cholesteatoma.
Yeşilova M; Görür K; Ismi O; Özcan C; Büyükafşar K
Otol Neurotol; 2017 Apr; 38(4):516-520. PubMed ID: 28288476
[TBL] [Abstract][Full Text] [Related]
59. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma.
Sakata K; Satoh M; Someya M; Asanuma H; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Cancer; 2004 Jan; 100(2):356-65. PubMed ID: 14716772
[TBL] [Abstract][Full Text] [Related]
60. External auditory canal cholesteatoma: analysis of the integrity of the tissue structure.
Naim R; Sadick H; Schafer C; Hormann K
Int J Mol Med; 2004 Oct; 14(4):601-4. PubMed ID: 15375588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
